DETECTION OF CASES OF PARVOVIRUS INFECTION IN THE SYSTEM FOR EPIDEMIOLOGICAL SURVEILLANCE OF EXANTHEMATIC DISEASES

Cover Page

Cite item

Abstract

The drastic decrease of the incidence of Measles and Rubella at the stage of elimination of these infections is notified on the territory of North- Western Federal Region (NWFR) of Russia. At the same time the number of cases with the error clinical diagnosis of Measles and Rubella increased. The most frequent error is the infection caused by Parvovirus (PVI). The disease is of the independent particular medical and social significance for obstetrics, maternity and childhood protection, blood donation service, transplantation of organs/tissue etc. The aim of the current study was to estimate the prevalence of PVI on the territory of NWFR of Russia in different periods of 2009–2012 and 2015–2016. The data of the laboratory diagnosis of PVI for patients with exanthema were analyzed. Materials and methods. The serum specimens of patients with exanthema from bank of sera of St. Petersburg Subnational Measles/Rubella laboratory, collected in 2009–2012 (n = 495) and in 2015 (n = 336) as well as 69 sera of patients with exanthema from the “Infectious Disease Hospital N30” in St. Petersburg, collected in March-May, 2016 were studied. The specific IgM-PV B19 antibodies were determined by the «recomWELL Parvovirus B19 IgM» (MICROGEN GmbH, Germany) ELISA test-system. The presen ce of the specific IgM-PV B19 antibodies in sera of patients was the evidence of the acute PVI. Results. The obtained results demonstrated the prevalence of PVI on the territory of NWFR. In 2009–2012 as well as in 2015 years PVI was revealed on the overwhelming majority (9 of 11) of administrative territories of the NWFR. The essential predominance of PVI was determined in St. Petersburg and bordering territories of NWFR (Kaliningrad Oblast’, Leningrad Oblast’, Republic of Karelia). In 2010, 2011 and 2015 years the part of sera detected as IgM-PV B19 positive on an average was equal to 14%. Meanwhile in 2012 the part of the detected IgM-PV B19 positive sera was statistically higher (p < 0.05) and consisted 45.5% of those tested in St. Petersburg Subnational Measles/Rubella laboratory. According to the results obtained the epidemical increase of PVI incidence was observed on the territory of NWFR in 2012. Among the cases with the laboratory confirmed PVI (i.e. IgM-PV B19 positive sera) the part of cases with the error clinical diagnosis of Rubella consisted 56.2% in 2012 and 34.0% in 2015. Comparing the initial clinical diagnosis of patients from the “Infectious Di sease Hospital N 30” in St. Petersburg in March-May, 2016, with the results of IgM-PV B19 ELISA of sera we revealed that none of patients with the laboratory confirmed PVI had the initial clinical diagnosis PVI at the stage of hospitalization. Thus the results obtained evidence the prevalence of PVI on the territory of NWFR; clinical diagnosis of PVI turns to be the problem for clinicians; the differential diagnosis of PVI with Rubella is necessary and of extremely importance at the stage of elimination of Measles and Rubella in Russia.

About the authors

I. N. Lavrentyeva

St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation

Author for correspondence.
Email: pasteur.lawr@mail.ru
PhD, MD (Medicine), Head of the Laboratory of Childhood Virus Infection, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation Russian Federation

A. Yu. Antipova

St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation

Email: fake@neicon.ru
PhD (Biology), Researcher, Laboratory of Childhood Virus Infection, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation Russian Federation

M. A. Bichurina

St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation

Email: fake@neicon.ru
PhD, MD (Medicine), Head of the Virology Laboratory by Elimination Measles and Rubella, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation Russian Federation

O. N. Nikishov

Military Medical Academy named after S.M. Kirov, St. Petersburg, Russian Federation

Email: fake@neicon.ru
Lecturer, Department of General and Military Epidemiology, Military Medical Academy named after S.M. Kirov, St. Petersburg, Russian Federation Russian Federation

N. V. Zheleznova

St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation

Email: fake@neicon.ru
PhD (Biology), Leading Reseacher, Laboratory of Viral Hepatitis, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation Russian Federation

A. A. Kuzin

Military Medical Academy named after S.M. Kirov, St. Petersburg, Russian Federation

Email: fake@neicon.ru
MD (Medicine), Associate Professor, Department of General and Military Epidemiology, Military Medical Academy named after S.M. Kirov, St. Petersburg, Russian Federation Russian Federation

References

  1. Алимбарова Л.М., Львов Д.К. Парвовирусные инфекции / Медицинская вирусология. Москва: МИА, 2008. С. 460–466. [Alimbarova L.M., Lvov D.K. Parvovirusnye infektsii [Infections of Parvoviruses]. Meditsinskaya virusologiya [In: Medical virology]. Moscow: MIA, 2008, рр. 460–466.]
  2. Антипова А.Ю., Лаврентьева И.Н., Бичурина М.А., Лялина Л.В., Кутуева Ф.Р. Распространение парвовирусной инфекции в Северо-Западном федеральном округе России // Журнал инфектологии. 2011. Т. 3, № 4. С. 27–34. [Antipova A.Yu., Lavrent’eva I.N., Bichurinа M.A., Lialina L.V., Kutueva F.R. The spread of parvovirus infection in the North-West federal district of Russia. Zhurnal infektologii = Journal of Infectology, 2011, vol. 3, no. 4, pp. 44–48. (In Russ.)]
  3. Бичурина М.А., Тимофеева Е.В., Железнова Н.В., Игнатьева Н.А., Шульга С.В., Лялина Л.В., Дегтярев О.В. Вспышка кори в детской больнице Санкт-Петербурга в 2012 году // Журнал инфектологии. 2013. Т. 5, № 2. С. 96–102. [Bichurina M.A., Timofeeva E.V., Zheleznova N.V., Ignatieva N.A., Shulga S.V., Lyalina L.V., Degtyarev O.V. Measles outbreak in the Children’s Hospital in Saint-Petersburg, 2012. Zhurnal infektologii = Journal of Infectology, 2013, vol. 5, no. 2, рр. 96–102. (In Russ.)]
  4. Ермолович М.А., Климович Н.В., Матвеев В.А., Самойлович Е.О., Романова О.Н., Черновецкий М.А. Сравнительные эпидемиологические аспекты парвовирусной В19 инфекции у больных с острыми экзантемными заболеваниями и гематологической патологией // Медицинский журнал. 2011. № 3. С. 61–65. [Yermolovich M.A., Klimovich N.V., Matveev V.A., Samoilovich E.O., Romanova O.N., Chernovetskiy M.A. Comparative epidemiological aspects of parvovirus B19 infection in patients with acute asanteni diseases and hematological pathology. Meditsinskii zhurnal = Medical Journal, 2011, no. 3, pp. 61–65. (In Russ.)]
  5. Краснуха: эпидемиология, лабораторная диагностика и профилактика в условиях спорадической заболеваемости: аналитический обзор. СПб.: НИИЭМ им. Пастера, 2010. 68 с. [Krasnukha: epidemiologiya, laboratornaya diagnostika i profilaktika v usloviyakh sporadicheskoy zabolevaemosti: analiticheskiy obzor [Rubella: epidemiology, laboratory diagnostic, prophylactic in sporadic period: analytic review]. St. Petersburg: St. Petersburg Pasteur Institute, 2010. 68 p.]
  6. Лаврентьева И.Н., Антипова А.Ю. Парвовирус В19 человека: характеристика возбудителя, распространение, диагностика обусловленной им инфекции // Инфекция и иммунитет, 2013. Т. 3, № 4. С. 311–322. [Lavrentyeva I.N., Antipova A.Yu. Human parvovirus B19: virus characteristics, distribution and diagnostics of parvovirus infection. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2013, vol. 3, no. 4, pp. 311–322. doi: 10.15789/2220-7619-2013-4-311-322 (In Russ.)]
  7. Матвеев В.А., Прощаева Н.В., Самойлович Е.О., Ермолович М.А. Клинико-лабораторная характеристика В19 парвовирусной инфекции // Инфекционные болезни. 2008. Т. 6, № 3. С. 33–37. [Matveev V.A., Proshchaeva N.V., Samoylovich E.O., Ermolovich M.A. B19 parvovirus infection clinical & laboratory characteristics. Infektsionnye bolezni = Infectious Diseases, 2008, vol. 6, no. 3, pp. 33–37. (In Russ.)]
  8. Тихонова Н.Т., Герасимова А.Г., Москалева Т.Н. Оценка распространения парвовирусной инфекции в Москве // Информационное письмо Комитета здравоохранения г. Москвы. М., 2004. № 11. 12 с. Tikhonova N.T., Gerasimova A.G., Moskaleva T.N. Otsenka rasprostraneniya parvovirusnoy infektsii v Moskve. Informatsionnoe pis`mo Komiteta zdravookhraneniya
  9. g. Moskvy [Evaluation of parvoviral infection prevalence in Moscow. Information letter Moscow department of public health]. Moscow, 2004, no. 11, 12 p.]
  10. Филатова Е.В., Новикова Н.А., Зубкова Н.В., Голицина Л.Н. Кузнецова К.В. Определение маркеров парвовируса В19 в крови доноров // Журнал микробиологии, эпидемиологии и иммунобиологии. 2010. № 5. С. 67–70. [Filatova E.V., Novikova N.A., Zubkova N.V., Golitsyna L.N., Kuznetsov K.V. Detection of parvovirus markers in blood samples. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2010, no. 5, pp. 67–70. (In Russ.)]
  11. Azadmanesh K., Mohraz M., Kazemimanesh M., Aghakhani A., Foroughi M., Banifazl M., Eslamifar A., Ramezani A. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV. J. Med. Virol., 2015, vol. 87, no. 7, pp. 1124–1129. doi: 10.1002/jmv.24169
  12. Douvoyiannis M., Litman N., David L. Neurologic manifestations associated with parvovirus B19 infection. Clin. Inf. Dis., 2009, vol. 48, pp. 1713–1723. doi: 10.1086/599042
  13. Marano G., Vaglio S., Pupella S., Facco G., Calizzani G., Candura F., Liumbruno G.M., Grazzini G. Human parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus., 2015, vol. 13, no. 2, pp. 184–196. doi: 10.2450/2014.0174.14
  14. Moudgil A., Nast C.C., Bagga A., Wei L., Nurmamet A., Cohen A.H., Jordan S.C., Toyoda M. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int., 2001, vol. 59, pp. 2126–2133. doi: 10.1046/j.1523-1755.2001.00727.x
  15. Progress towards elimination of measles and prevention of congenital rubella infection in the WHO Europian region. 1999–2004. Wkly Epidemiol. Res., 2005, vol. 80, no. 8, pp. 66–71.
  16. Satake M., Hoshi Y., Taira R., Momose S.Y., Hino S., Tadokoro K. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion, 2011, vol. 51, pp. 1887–1895. doi: 10.1111/j.1537-2995.2010.03047.x
  17. US Food Drug Administration. Guidance for Industry: Nucleic acid testing (NAT) to reduce the possible risk of parvovirus B19 transmission by plasma-derived products. 2009.

Copyright (c) 2016 Lavrentyeva I.N., Antipova A.Y., Bichurina M.A., Nikishov O.N., Zheleznova N.V., Kuzin A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies